Understanding the perimenopause

Women's Health

Volumn 3, Issue 4, 2007, Pages 387-390

  Weiss, Gerson ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BENZODIAZEPINE DERIVATIVE; ESTROGEN; FOLLISTATIN; FOLLITROPIN; GESTAGEN; INHIBIN; LUTEINIZING HORMONE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEROTONIN UPTAKE INHIBITOR; STEROID HORMONE;

ANOVULATION; CLIMACTERIUM; COITUS; EDITORIAL; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM POLYP; FEMALE FERTILITY; HEADACHE; HORMONE SYNTHESIS; HOT FLUSH; HUMAN; HYSTERECTOMY; LOW DRUG DOSE; LUTEAL PHASE; MENSTRUAL CYCLE; NONHUMAN; OVARY FOLLICLE ATRESIA; OVARY POLYCYSTIC DISEASE; OVULATION; PREGNANCY; SLEEP DISORDER; SPONTANEOUS ABORTION; SYMPTOMATOLOGY; UTERUS BLEEDING; UTERUS MYOMA; WOMEN'S HEALTH;

EID: 34447580928     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/17455057.3.4.387     Document Type: Editorial

References (15)

1. Brambilla DJ, McKinlay SM, Johannes CB: Defining the perimenopause for application in epidemiologic investigation. Am. J. Epidemiol. 140, 1091-1095 (1994).
2. Weiss G: Fertility in the older woman. Clin. Consult. Obstetrics Gynecology 8, 56-59 (1996).
3. Gray RH: Social influences in fertility at later ages of reproduction. J. Biosoc. Sci. 6(Suppl.), 97-115 (1979).
4. Menken J, Trussell J, Larser V: Age and infertility. Science 233, 1389-1394 (1986).
5. Hayes FJ, Hall JE, Boepple PA, Crowley WF Jr: Differential control of gonadotropin secretion in the human: endocrine role of inhibin. J. Clin. Endocrinol. Metab. 83, 1835-1841 (1998).
6. Santoro N, Brown JR, Adel T, Skurnick JH: Characterization of reproductive hormonal dynamics in the perimenopause. J. Clin. Endocrinol. Metab. 81, 1495-1501 (1996).
7. Weiss G: Clinical and Scientific Significance of Perimenopausal Changes in Pituitary and Ovarian Hormone Secretion. Chapter 5. In: Biology of Menopause, Francis L Bellino (Ed.), Springer Publishers, New York, NY, USA, 45-53 (2000).
8. Bourguiganon J, Hoyoux C, Reuten A, Franchimont: Urinary excretion of immunoreactive luteinizing hormone-releasing hormone-like material and gonadotropins at different stages of life. J. Clin. Endocrinol. Metab. 48, 78-84 (1979).
9. Nelson H, Humphrey L, Nygren P, Teutsch S, Allan J: Postmenopausal hormone replacement therapy. JAMA 288, 872-881 (2002).
10. Knab DR: Estrogen and endometrial carcinoma. Obstet. Gynecol. Surv. 32, 267 (1979).
11. Whitehead M, Lane G, Siddle N, Townsend P, King R: Avoidance of endometrial hyperstimulation in estrogen-treated postmenopausal women. Semin. Reprod. Endocrinol. 11, 41-53 (1983).
12. Graves EJ: National Center for Health Statistics: National hospital discharge survey: annual summary, 1990. Vital and health Statistics. (Series 13) No. 112. Washington, DC, Government Printing office 1992, CDHAS publication no. (PHS), 92-1773 (1990).
13. Merrill JA, Creasman WT: Benign lesions of the uterine corpus. In: Danforth's Obstetrics and Gynecology. Sixth Ed. Scott JR, Disaia PJ, Hammond CR,. Spellacy WN (Eds), Lippincott, Philadelphia, PA, USA, 1023-1054 (1990).
14. Talbert LM, Kauma SM: Endometriosis. In: Danforth's Obstetrics and Gynecology. Sixth Ed. Scott JR, Di Saia PJ, Hammond CB, Spellacy WN (Eds), Lippincott, Philadelphia, PA, USA, 845-852 (1990).
15. Weiss G: Management of uterine myomata. In: Infertility: evaluation and treatment. Keye WR, Chang RJ, Rebar RW, Soules, MR (Eds), WB Saunders, Philadelphia, PA, USA, 412-424 (1994).